trial · primary record
Sodium Thiosulfate
Peritoneal Mesothelioma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2034-12-30 |
| Primary endpoint | To determine the correlation between ex vivo simulated HIPEC in the SMART System or 3-D cell culture (organoid) models, and in vivo HIPEC with respect to two measures of response to treatment: percent necrosis and Ki-67 |
| Registry ID | NCT04847063 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:12.378Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04847063
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- SODIUM THIOSULFATE · approval
- Sodium Thiosulfate · compound